Amador Bioscience is a Translational & Clinical CRO providing quantitative clinical pharmacology, GLP/GCLP bioanalysis and biomarkers, clinical research, and regulatory filing services to biopharmaceutical companies in USA, China and EU. Amador facilitates innovative drug development from discovery to clinical development and global regulatory fillings. Our clients range from cutting-edge biotech startups to industry-leading multinationals.
| Website | https://www.amadorbioscience.com/ |
| Revenue | $16.8 million |
| Employees | 59 (4 on RocketReach) |
| Founded | 2018 |
| Address | 4695 Chabot Dr 200-265, Pleasanton, California 94588, US |
| Phone | +1 925-558-2709 |
| Industry | Biotechnology Research |
| Keywords | Clinical Pharmacology, Clinical Research Services, Cro, Drug Development, Clinical Trials, Clinical Development, Bioanalysis, Biopharmaceutical Services, Pharmacokinetics, Pharmacodynamics, Biomarkers, Gxp, Translational Research, Biomarker Discovery, Drug Discovery, Regulatory Affairs, Glp |
| Competitors | Labcorp, Charles River Laboratories, Parexel, Covance, Medpace, PPD, Syneos Health, IQVIA, Softheon, Eisai Co., Ltd. +26 more (view full list) |
Looking for a particular Amador Bioscience employee's phone or email?
The Amador Bioscience annual revenue was $16.8 million in 2026.
Meina Liang is the Chief Scientific Officer (CSO), Head of Bioanalysis and Biomarkers of Amador Bioscience.
4 people are employed at Amador Bioscience.
Amador Bioscience is based in Pleasanton, California.